Continual disclosure regarding re-appointment of Executive Directors.
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech has re-appointed two of its Executive Directors — Ms. Anupama Datla Desai and Mr. Satish Varma — each for a fresh three-year term starting September 27, 2025 to September 26, 2028. Both directors were approved by shareholders at the August 12, 2025 general meeting and continue as Key Managerial Personnel. The company notes Anupama Datla Desai is daughter of non-executive director Rajeshwari Datla and sister of Executive Vice Chairman Krishna Datla, confirming she is part of the promoter Datla family. Mr. Satish Varma brings over 30 years of experience and was previously instrumental in the Solvay demerger and the Crocin brand sale.
This is a routine continuity announcement — the same directors continue in their existing roles, so no major change is expected for shareholders. The re-appointment of a promoter-family director reinforces existing management control rather than introducing any new leadership or governance shift.